Lexicon Pharmaceuticals (LXRX) Retained Earnings: 2009-2011
Historic Retained Earnings for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$789.6 million.
- Lexicon Pharmaceuticals' Retained Earnings fell 15.77% to -$875.0 million in Q3 2012 from the same period last year, while for Sep 2012 it was -$875.0 million, marking a year-over-year decrease of 15.77%. This contributed to the annual value of -$789.6 million for FY2011, which is 17.26% down from last year.
- Lexicon Pharmaceuticals' Retained Earnings amounted to -$789.6 million in FY2011, which was down 17.26% from -$673.4 million recorded in FY2010.
- Over the past 5 years, Lexicon Pharmaceuticals' Retained Earnings peaked at -$570.2 million during FY2009, and registered a low of -$789.6 million during FY2011.
- In the last 3 years, Lexicon Pharmaceuticals' Retained Earnings had a median value of -$673.4 million in 2010 and averaged -$677.7 million.
- Data for Lexicon Pharmaceuticals' Retained Earnings shows a maximum YoY declined of 18.11% (in 2010) over the last 5 years.
- Lexicon Pharmaceuticals' Retained Earnings (Yearly) stood at -$570.2 million in 2009, then dropped by 18.11% to -$673.4 million in 2010, then declined by 17.26% to -$789.6 million in 2011.